Clinical Commentaries

Clinical Commentaries published on August 10, 2017
Dr. Garcia-Manero provides an overview of current U.S. clinical trials in MDS and a detailed discussion of a study examining oral azacitidine (CC-486).
Clinical Commentaries published on August 8, 2017
Dr. Germing provides a succinct summary of key changes made in 2016 to the World Health Organization's MDS classifications.
Clinical Commentaries published on August 1, 2017
Dr. Naval Daver provides an update on one of the first studies to evaluate immune checkpoint treatment in patients with MDS, a phase 2 trial comparing nivolumab/azacitidine and ipilimumab/azacitidine.
Clinical Commentaries published on July 18, 2017
In this Clinical Commentary, Sandra Kurtin discusses the benefits of teaching patients and caregivers to use a healthcare mobile app to self-manage their MDS.

Results 1 - 4 of 4

MediCom Worldwide, Inc. would like to thank Celgene Corporation and Onconova Therapeutics Inc. for their educational support of

©2018 MediCom Worldwide, Inc. All rights reserved